Impulsivity Domains and Subjective Response
Jessica Weafer · with National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NCT05929677
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–25 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Early Phase 1
- Target enrollment
- 250
- US sites recruiting
- 2
- Study start
- April 1, 2024
- Record last updated
- May 22, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Findings from this project will determine the relationship between two vulnerability factors for Alcohol Use Disorder (AUD) in young adults: impulsivity and subjective response to alcohol. The results will identify badly needed, novel targets for prevention and treatment efforts to simultaneously reduce impulsivity and subjective responses in at-risk young adults.
Being studied: Placebo; Alcohol
Conditions: Alcohol Use Disorder
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 21-25 years old
- Report drinking to an estimated BAC > .08% at least once in the past 30 days based on responses on the Timeline Followback (TLFB)
- Report drinking at least twice weekly in the past 30 days based on responses on the TLFB
- Fluency in English
Exclusion Criteria
- Any serious medical problems (e.g., liver disease, cardiac abnormality, pancreatitis, diabetes, neurological problems, and gastrointestinal disorders)
- Body weight \< 110 or > 210 pounds
- Axis I psychiatric disorders including substance use disorder other than mild or moderate alcohol or mild cannabis use disorder
- Current alcohol withdrawal or history of medically-assisted detoxification
- Two positive breath alcohol concentration (BrAC) readings (i.e., > 0.00%) at an in-person screening appointment or experimental session
- Positive urine screen for illegal drugs other than cannabis
- Currently seeking or past-12-month history of inpatient or intensive treatment for addictive behaviors
- Current psychotropic medication use or receipt of a prescription for these medications in the past 30 days
- Psychosis or other psychiatric disability
- Pregnancy, nursing or lack of reliable birth control use for women
- Report smoking > 5 cigarettes per day (to avoid acute nicotine effects or withdrawal during experimental sessions)
Recruiting US locations
Northeastern University
Boston, MA 02115
Site contact: Robert Leeman · 617-373-6501 · r.leeman@northeastern.edu
Ohio State University
Columbus, OH 43221
Site contact: Jessica Weafer, PhD · 614-257-2075 · jessica.weafer@osumc.edu
Study contacts (from the official record)
- Jessica Weafer, PhD · 614-257-2075 · jessica.weafer@osumc.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+